Question 1 · Hard
A tracheal aspirate from a ventilated patient who has received meropenem for 10 days grows a non-lactose-fermenting gram-negative rod that is resistant to meropenem and imipenem but susceptible to trimethoprim-sulfamethoxazole. The laboratory has no MALDI-TOF and must decide whether to raise a carbapenem-resistant organism alert for infection control. Results: TSI K/K (no change); oxidase negative; motile; DNase positive; lysine decarboxylase positive; good growth on MacConkey agar at 24 hours; no growth on CNA agar. What is the best interpretation?
- ABurkholderia cepacia complex; refer it
- BStenotrophomonas; the resistance is intrinsic
- CAcinetobacter baumannii; raise a CRAB alert
- DP. aeruginosa; test for a carbapenemase
Show answerHide answer
Answer: B · Stenotrophomonas; the resistance is intrinsic
An oxidase-negative, motile, DNase-positive and lysine-positive non-fermenter is Stenotrophomonas maltophilia. Acinetobacter is non-motile and DNase negative, Pseudomonas aeruginosa is oxidase positive, and the Burkholderia cepacia complex is DNase negative and usually weakly oxidase positive. S. maltophilia carries the chromosomal L1 metallo-beta-lactamase, so it is intrinsically resistant to carbapenems, and long carbapenem therapy selects it. Its carbapenem resistance is expected and does not call for a carbapenemase alert; trimethoprim-sulfamethoxazole is the usual treatment.
- A: The B. cepacia complex is DNase negative and usually weakly oxidase positive.
- C: Acinetobacter is non-motile and DNase negative.
- D: P. aeruginosa is oxidase positive.